Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
| Particulars | Details |
|---|---|
| Title |
Rate Contact Of Insulin Lispro(25 Percent ), Insulin Lispro Protamine(75 Percent ) Cartridge, 3 Ml Cartridges With One Compatible Device Per Fifty Cartridges (Penfills) Free Of Cost. Note : (1) This Is A Rate Contract (Rc) Tender.(2) Quantity N (In The Tender) Is Only Indicative, Which Can Be Increased Or Decreased Depending Upon The Requirement During The Validity Of The Rc . (3)there Is No Guarantee Of Order Quantity. (4)the Validity Of Rc Shall Be One Years Which Can Be Extended By Anoth
|
| Description |
For Complete Deion And Other Details, Please Refer To Tender
|
| Organisation | Ministry of Railways | Central Govt. Ministry/Department |
| Tender Id | 75681287 |
|
Reference Number |
RDSO24251542 |
| Tender Fee | 0 |
| EMD | 0 |
| Tender Value | - |
| Place | LUCKNOW |
| Link |
View Original Tender Notice
https://www.ireps.gov.in/ireps/supply/pdfdocs/072024/75681287/viewNitPdf_4606179.pdf |
| Start Date | June 14, 2024 16:24 |
| End Date |
Expired
01/07/2024
Expired 834 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
(ph no.:10061) monocomponent insulin recombinant dna origin 25 percent insulin lispro and 75 percent insulin lispro protaminesuspension - 100 iu/ ml -3 ml -penfills/ cartridges (1free pen per 45 penfills).
For complete deion and other details, please refer to tender
Read more(ph no.:10061) monocomponent insulin recombinant dna origin 25 percent insulin lispro and 75 percent insulin lispro protamine suspension - 100 iu/ ml -3 ml - penfills/ cartridges (1free pen per 45 penfills).
For complete deion and other details, please refer to tender
Read moreZonal rate contract for supply of (ph no.:10061) monocomponent insulin recombinant dna origin 25 percent insulin lispro and 75 percent insulin lispro protamine suspension - 100 iu/ ml -3 ml - penfills/ cartridges (1free pen per 45 penfills).
For complete deion and other details, please refer to tender
Read more(ph no.:10062) monocomponent insulin recombinant dna origin 50 percent insulin lispro and 50 percent insulin lispro protamine suspension - 100 iu /ml - 3 ml- penfills/ cartridges (1 free pen per 45 penfills).
For complete deion and other details, please refer to tender
Read moreMonocomponent insulin recombinant dna origin 25 percent insulin lispro and 75 percent insulin lispro protamine suspension - 100 iu x 1 ml x 3 ml - penfills/ cartridges
For complete deion and other details, please refer to tender
Read moreInj. insulin lispro 25 percent 75 percent insulin lispro protamine suspension - 100iu / ml 3ml- penfills / cartridges (one pen and 50 needles free with 50 cartridges) per unit
For complete deion and other details, please refer to tender
Read moreGte zonal rate contract for supply of (ph no.:10061) monocomponent insulin recombinant dna origin 25 percent insulin lispro and 75 percent insulin lispro protamine suspension - 100 iu/ ml -3 ml - penfills/ cartridges (1free pen per 45 penfills).
For complete deion and other details, please refer to tender
Read moreGte zonal rate contract for supply of (ph no.:10062) monocomponent insulin recombinant dna origin 50 percent insulin lispro and 50 percent insulin lispro protamine suspension - 100 iu /ml - 3 ml- penfills/ cartridges (1 free pen per 45 penfills).
For complete deion and other details, please refer to tender
Read moreInj. insulin recombinant dna origin 50 percent insulin lispro 50 percent insulin lispro protamine suspension - 100 iu / ml - 3 ml- penfills/ cartridges (one pen 50 needles free with 50 cartridges) per unit
For complete deion and other details, please refer to tender
Read moreInj. insulin recombinant dna origin 50 percent insulin lispro 50 percent insulin lispro protamine suspension - 100 iu / ml - 3 ml- penfills/ cartridges (one pen 50 needles free with 50 cartridges) per unit
For complete deion and other details, please refer to tender
Read moreof your Industry type